Cargando…

The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH

Non-alcoholic fatty liver disease (NAFLD) is a multimorbidity disorder ranging from excess accumulation of fat in the liver (steatosis) to steatohepatitis (NASH) and end-stage cirrhosis, and the development of hepatocellular carcinoma (HCC) in a subset of patients. The defining features of NASH are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dashek, Ryan J., Diaz, Connor, Chandrasekar, Bysani, Rector, R. Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564138/ https://www.ncbi.nlm.nih.gov/pubmed/34745017 http://dx.doi.org/10.3389/fendo.2021.770740

Ejemplares similares

Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration
por: Chandrasekar, Bysani, et al.
Publicado: (2023)

Current and Potential Therapies Targeting Inflammation in NASH
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Hepatic Stellate Cell-Immune Interactions in NASH
por: Carter, James K., et al.
Publicado: (2022)

Editorial: Immune mechanisms of inflammation in NASH
por: Hirsova, Petra, et al.
Publicado: (2022)

Identification of ferroptosis-related genes in the progress of NASH
por: He, Linwei, et al.
Publicado: (2023)

Reck's Steam Disinfector
Publicado: (1895)

The Reck System of Heating
Publicado: (1912)

TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism
por: Shepard, Christopher R.
Publicado: (2021)

Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH
por: Bonnet, Laurianne, et al.
Publicado: (2022)

The role of oxidized lipid species in insulin resistance and NASH in children
por: Santoro, Nicola, et al.
Publicado: (2022)

GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
por: Li, Qiu-Xuan, et al.
Publicado: (2021)

Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction
por: Guo, Mingwei, et al.
Publicado: (2022)

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
por: Kořínková, L., et al.
Publicado: (2020)

Autophagy and its therapeutic potential in diabetic nephropathy
por: Han, Yu-Peng, et al.
Publicado: (2023)

Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH
por: Jadhav, Kavita, et al.
Publicado: (2020)

Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones
por: Liu, Qiuhong, et al.
Publicado: (2022)

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Expression of RECK and matrix metalloproteinase-2 in ameloblastoma
por: Zhang, Bin, et al.
Publicado: (2009)

Samara Reck-Peterson: Dynein defies expectations
por: Sedwick, Caitlin
Publicado: (2013)

RECK is not an independent prognostic marker for breast cancer
por: Gomes, Luciana R., et al.
Publicado: (2015)

Corrigendum: Role of aerobic exercise in ameliorating NASH: Insights into the hepatic thyroid hormone signaling and circulating thyroid hormones
por: Liu, Qiuhong, et al.
Publicado: (2023)

RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
por: Chen, Shao-Long, et al.
Publicado: (2021)

Production of Hydrogen Sulfide from D-Cysteine and Its Therapeutic Potential
por: Shibuya, Norihiro, et al.
Publicado: (2013)

RECK isoforms have opposing effects on cell migration
por: Lee, Ha Neul, et al.
Publicado: (2018)

Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms
por: Herbster, Suellen, et al.
Publicado: (2021)

Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
por: Wang, Jing-Hua
Publicado: (2023)

Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter]
por: Shuja, Syed Hasan, et al.
Publicado: (2021)

Labeled breath tests in patients with NASH: Octanoate oxidation relates best to measures of glucose metabolism
por: Mucinski, Justine M., et al.
Publicado: (2023)

Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1
por: Simonds, William F.
Publicado: (2023)

Editorial: New insights into multiple endocrine neoplasia type 1
por: Barlier, Anne, et al.
Publicado: (2023)

Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
por: Chimento, Adele, et al.
Publicado: (2019)

Curcumin supplementation mitigates NASH development and progression in female Wistar rats
por: Cunningham, Rory P., et al.
Publicado: (2018)

The Expression of Markers for Intratubular Germ Cell Neoplasia in Normal Infantile Testes
por: Kvist, Kolja, et al.
Publicado: (2018)

Preimplantation Genetic Testing of Multiple Endocrine Neoplasia Type 2A
por: Würgler Hansen, Anders, et al.
Publicado: (2020)

Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications
por: Tonelli, Francesco, et al.
Publicado: (2018)

Reck enables cerebrovascular development by promoting canonical Wnt signaling
por: Ulrich, Florian, et al.
Publicado: (2016)

Critical roles for murine Reck in the regulation of vascular patterning and stabilization
por: de Almeida, Glícia Maria, et al.
Publicado: (2015)

The RECK tumor-suppressor protein binds and stabilizes ADAMTS10
por: Matsuzaki, Tomoko, et al.
Publicado: (2018)

Suppression of tumor metastasis by a RECK-activating small molecule
por: Yoshida, Yoko, et al.
Publicado: (2022)

Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis
por: Houttu, Veera, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9r27t0ovla86m61mm0bvgf3cfj